CHH:CA:TSX-CareRx Corporation (CAD)

COMMON STOCK | Medical Care Facilities | TSX

Last Closing Price

CAD 0.23

Change

0.00 (0.00)%

Market Cap

CAD 4.68M

Volume

0.22M

Average Target Price

N/A
Average Analyst Rating

N/A

Fundamental Analysis

Verdict

About

Centric Health Corporation provides pharmacy and other healthcare services to patients and customers in Canada. The company operates a network of pharmacy fulfilment centers that provide chronic medication and other specialty clinical pharmacy services for long term care and retirement communities, and assisted living facilities. It serves approximately 31,000 residents in 460 senior communities through a network of fulfilment centers. The company was formerly known as Alegro Health Corp. and changed its name to Centric Health Corporation in August 2009. Centric Health Corporation was incorporated in 2001 and is headquartered in Toronto, Canada.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-12-04 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
SIA:CA Sienna Senior Living Inc

-0.13 (-0.95%)

CAD0.92B 181.00 19.92
EXE:CA Extendicare Inc

-0.19 (-2.77%)

CAD0.62B 13.31 8.86
DR:CA Medical Facilities Corporation

-0.27 (-3.58%)

CAD0.23B 10.47 3.15
IVQ:CA Invesque Inc

-0.07 (-3.10%)

CAD0.13B -99,999.99 N/A
GTMS:CA Greenbrook TMS Inc

-0.03 (-2.01%)

CAD0.10B N/A N/A
CRRX:CA CareRx Corporation

-0.16 (-4.21%)

CAD0.09B N/A N/A

ETFs Containing CHH:CA

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Medical Care Facilities)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 45.16% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 45.16% N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain 45.16% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 45.16% N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain -22.41% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return -22.41% N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 22.81% N/A N/A 90% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 22.81% N/A N/A 90% A-
Risk Return Profile  
Volatility (Standard Deviation) 144.36% N/A N/A 3% F
Risk Adjusted Return 15.80% N/A N/A 40% F
Market Capitalization 4.68M N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Care Facilities)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 10.50 N/A N/A N/A N/A
Price/Book Ratio N/A N/A N/A N/A N/A
Price / Cash Flow Ratio 0.74 N/A N/A N/A N/A
EV/EBITDA 19.49 N/A N/A N/A N/A
Management Effectiveness  
Return on Equity N/A N/A N/A N/A N/A
Return on Invested Capital -14.22% N/A N/A N/A N/A
Return on Assets -1.03% N/A N/A N/A N/A
Debt to Equity Ratio -65.10% N/A N/A N/A N/A
Technical Ratios  
Short Ratio 2.65 N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 0.74 N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:

There is nothing we particularly dislike